Cureous Labs raises Rs 1.66 Cr in seed round

Bengaluru-based medical technology startup Cureous Labs has raised Rs 1.66 crore in a seed round led by Inflection Point Ventures (IPV), with participation from Anthill Ventures. 

The proceeds will be used to manufacture the first batch of its flagship product Eturnal, build inventory, expand its sales and business development team, launch its first disinfection centre, and complete product safety testing and certifications. 

Cureous Labs also plans to expand its portfolio for B2B customers in India.

Founded by Asish Mohandas, Cureous Labs develops automated patient repositioning systems to prevent pressure injuries and improve caregiver efficiency. Priced at one-fifth of international alternatives, the device is designed for hospitals, rehabilitation centres, and home care. 

According to the company, it has already logged over 30,000 hours of use and more than 14,000 automated patient turns.

As per market research, the global market for elderly and bedridden patient care is valued at $277 billion. In India, the total addressable market is $8.34 billion.